Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs as Cancer Therapeutics

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2017.00273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection

Frontiers in Microbiology
Microbiology
2015English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

ReDO_DB: The Repurposing Drugs in Oncology Database

ecancermedicalscience
Cancer ResearchOncology
2018English

Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy

Frontiers in Pharmacology
Pharmacology
2020English

Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially Available Drugs Through Machine Learning and Docking

2020English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Repurposing in 2020: Teaching Old Drugs New Tricks

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
2020English

Repurposing Drugs, and Fresh Outcomes From Other Familiar Sources

Microbe
Microbiology
2016English

Identification of NUDT5 Inhibitors From Approved Drugs

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy